Five-year survival and use of hospital services following ICD and CRT implantation: comparing real-world data with RCTs.

ABSTRACT:

Aims

Guidelines recommend the use of an implantable cardioverter-defibrillator (ICD) and/or cardiac resynchronization therapy (CRT) device based on the results of randomized controlled trials (RCTs), typically with selected patients and short follow-up.

Methods and results

We describe the 5 year survival rate and use of hospital services following ICD and CRT implantation in England from April 2011 to March 2013 using the national hospital administrative database covering emergency department visits, inpatient admissions, and clinic appointments, linked to the national death register. Five-year survival was 64% after ICD implantation and 58% after CRT implantation, with median survival times of 6.8 and 6.2 years, respectively. Hospital use was high in both device groups, for

SUBMITTER: Bottle A 

PROVIDER: S-EPMC8318487 | biostudies-literature | 2021 Aug

REPOSITORIES: biostudies-literature